Navigation Links
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Date:12/14/2009

INDIANAPOLIS, Dec. 14 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) approved ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company (NYSE: LLY) announced today. ZYPREXA RELPREVV, a long-acting intramuscular injection, sustains the delivery of olanzapine for up to four weeks.

Different from both oral and injected short-acting formulations, long-acting formulations of antipsychotics allow for stable concentrations of the active drug to remain at a therapeutic range for an extended period of time.(i)

"Patients, families and communities often needlessly suffer the consequences of relapse when daily schizophrenia medications are not taken as prescribed," said John Kane, M.D., chairman, Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, N.Y. "ZYPREXA RELPREVV gives patients an additional treatment option that can help them maintain therapeutic drug levels for up to four weeks at a time."

Approximately 2.4 million Americans or about 1.1 percent of the adult population have schizophrenia.(ii) Schizophrenia is a brain disorder characterized by acute episodes of delusions (false beliefs that cannot be corrected by reason) and hallucinations (usually in the form of non-existent voices), as well as long-term impairments such as diminished emotion, general lack of interest and depressive signs and symptoms.(iii,iv)

Proper treatment for schizophrenia can relieve symptoms, prevent or delay relapse and break the "revolving door" cycle often associated with schizophrenia.(v,vi) Non-adherence to antipsychotic medications greatly increases the risk of relapse in patients with schizophrenia.(vii) By administering long-acting medications, psychiatrists know when patients hav
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Zyprexa for Two Adolescent Indications
2. US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
3. FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
4. FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
5. FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
6. FDA Approves Agriflu Seasonal Influenza Vaccine
7. FDA Approves Lysteda to Treat Heavy Menstrual Bleeding
8. Rogan-Delft Approves Matrox Xenia Series for Use With Zillion Suite
9. FDA approves GlaxoSmithKlines VOTRIENT(TM) for advanced renal cell cancer
10. FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
11. FDA Approves New Treatment for Advanced Form of Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015   Surefire ... a prospective clinical trial comparing the Surefire Infusion System ... either primary or metastatic liver cancer, using the ... uptake of embolic agents, and with significantly decreased ... presented today at the Society of Interventional ...
(Date:3/3/2015)... 3, 2015  UnaliWear announces the market preview of ... seniors that guards against wandering and provides support for ... wearable – the Kanega watch ( http://www.UnaliWear.com ) – ... an easy speech interface rather than buttons, use cellular ... input. The watch goes wherever the ...
(Date:3/3/2015)... Ariz. , March 3, 2015  Michigan brothers ... heart condition called arrhythmogenic right ventricular dysplasia, or ARVD, a ... cause of sudden death among young athletes. In ... at a basketball game. They later tested Dominique and found ... to a February 19, 2015 story in The Ann ...
Breaking Medicine Technology:Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3
(Date:3/3/2015)... Anik Singal's Profit Academy - a ... has become the talk of the town throughout ... the course's general release has garnered the attention ... to review the program's content and publish an ... keys to success with Internet marketing is having ...
(Date:3/3/2015)... 2015 On February 21st, the rooftop ... EcoLuxe Lounge, a day-long event that features a gathering ... and services. Organized by Debbie Durkin and Durkin Entertainment, ... producer, the EcoLuxe Lounge saw many notable attendees. Among ... General Hospital, The Flash, Star Trek: Deep Space Nine ...
(Date:3/3/2015)... Findings could lead to better therapies ... have developed and characterized a molecule that interferes with ... self-destruct. This novel mechanism was found to be effective ... type of brain cancer – and could be applicable ... to be published in the April 2015 issue of ...
(Date:3/3/2015)... The Rheumatology Nurses Society (RNS) is ... and safe practice for patients with rheumatic diseases. , ... infusions are administered in an infusion center, provider’s office, ... nurse (RN), as defined in their State Nurse Practice ... receiving these medications during a first infusion, as well ...
(Date:3/3/2015)... The report “Alopecia – Pipeline Review, H1 ... Alopecia. Alopecia is the loss of hair. Alopecia areata ... alopecia. Causes for alopecia include aging, genetics, illness, chemotherapy, ... male pattern hair loss, female diffuse hair loss, hairs ... as focal or diffuse and by the presence or ...
Breaking Medicine News(10 mins):Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Hollywood Star Chase Masterson and Choices Recovery Discuss Substance Abuse and Treatment at 2015 Oscars 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4
... Nov. 19 Mangos, a full-service advertising,agency, recently received ... a leading healthcare publication. The competition recognizes,exceptional creativity ... for the first time this year, and was the ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081119/AQW573 ...
... 19 Governor Edward G. Rendell today revised his ... Health Care Cost Containment Council (PHC4). Under the revised order, ... or until the General Assembly reauthorizes the council, whichever occurs ... Governor acted similarly in 2003 when PHC4 was allowed to ...
... ALEXANDRIA, Va., Nov. 19 Recognizing November 20th as ... Cancer Society, the National Community Pharmacists Association House of ... to consider refraining from selling tobacco products in their ... pharmacies are renowned for helping their patients to maintain ...
... Consumer Watchdog said the health insurance industry,s support today ... it includes a requirement that every American buy insurance ... self-serving. The proposal amounts only to a customer delivery ... will not solve America,s health care problems and will ...
... Methodist University in Dallas are pioneering the use of ... Persian Gulf War veterans, aiming to pinpoint specific areas ... , Richard Gunst, Wayne Woodward and William Schucany, professors ... specialists at UT Southwestern Medical Center to compare brain ...
... And more is coming. At The University of Texas ... trainees are learning how to address the many issues ... received a 5-year, $1.3 million grant from the Agency ... young investigators how to conduct research in health information ...
Cached Medicine News:Health News:Mangos Wins Two Gold Awards 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 3Health News:NCPA Encourages Member Pharmacists to Consider Refraining From Selling Tobacco Products 2Health News:Consumer Watchdog Comments on Health Insurer's Self-Serving Support of 'Individual Mandate' 2Health News:Deep brain mapping to isolate evidence of Gulf War syndrome 2Health News:UT trainees tackle health information technology issues 2Health News:UT trainees tackle health information technology issues 3
Bayonet forceps....
Hardy bayonet forceps with stops. Insulated....
Cushing bayonet forceps. Insulated....
Insulated Bipolar Forceps...
Medicine Products: